Tyrosine Kinase Inhibitors and Their Role in Treating Patients With Neovascular AMD or Diabetic Macular Oedema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Eye (London, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tyrosine Kinase Inhibitors and their role in treating neovascular age-related macular degeneration and diabetic macular oedema
Eye (Lond) 2023 Dec 01;37(18)3725-3733, S Chandra, EY Tan, T Empeslidis, S SivaprasadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.